Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €147.49 million as of January 14, 2025. Its market cap has decreased by -32.12% in one year.

Market Cap

147.49M

Enterprise Value

91.20M

Revenue

33.79M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.82

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 147.49M, an increase of 18,519.95%. That is a compound annual growth rate of 33.23%.

Market Cap History

Date	Market Cap	% Change
Jan 14, 2025	147.49M	-5.69%
Dec 31, 2024	156.40M	-25.96%
Dec 29, 2023	211.24M	-19.93%
Dec 30, 2022	263.84M	-24.98%
Dec 31, 2021	351.67M	28.64%
Dec 31, 2020	273.37M	-41.60%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sanofi	116.34B
EssilorLuxottica Société anonyme	106.42B
Sartorius Stedim Biotech	19.66B
bioMérieux	12.98B
Ipsen	9.78B
Eurofins Scientific SE	8.67B
Virbac	2.63B
Ramsay Générale de Santé	1.40B

Market Cap Rankings